Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus

Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus

Abstract Background From three days following host attachment, the Australian paralysis tick, Ixodes holocyclus, secretes a neurotoxin that annually causes paralysis in approximately 10,000 domestic pets. Lotilaner, a novel isoxazoline formulated in a chewable flavoured tablet (CredelioTM), produces...

Full description

Bibliographic Details
Main Authors: Kim Baker, Claudia Ellenberger, Martin Murphy, Daniela Cavalleri, Wolfgang Seewald, Jason Drake, Steve Nanchen, Kristina Hacket
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Parasites & Vectors
Subjects:
Credelio
Dog
Ixodes holocyclus
Lotilaner
Paralysis tick
Online Access:http://link.springer.com/article/10.1186/s13071-018-3061-8

Internet

http://link.springer.com/article/10.1186/s13071-018-3061-8

Similar Items